FAP and neoplasm: A mouse breast cancer model revealed that epirubicin conjugated with a FAP-specific dipeptide (Z-Gly-Pro) effectively releases epirubicin after incubation with FAP, and epirubicin induces a substantial anti-tumor effect in cells with high FAP expression (4T1) (Figure 3B).